June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Risk Factors Associated with Cystoid Macular Edema After Boston Keratoprosthesis Type 1 Implantation
Author Affiliations & Notes
  • Kaitlyn Wallace
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Joshua Hou
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Randee Miller
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Clement Chow
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Jose De la Cruz
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Felix Chau
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Maria Cortina
    UIC Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, Chicago, IL
  • Footnotes
    Commercial Relationships Kaitlyn Wallace, None; Joshua Hou, None; Randee Miller, None; Clement Chow, None; Jose De la Cruz, alcon (C), amo (C); Felix Chau, None; Maria Cortina, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 3462. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kaitlyn Wallace, Joshua Hou, Randee Miller, Clement Chow, Jose De la Cruz, Felix Chau, Maria Cortina; Risk Factors Associated with Cystoid Macular Edema After Boston Keratoprosthesis Type 1 Implantation. Invest. Ophthalmol. Vis. Sci. 2013;54(15):3462.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: 1) To evaluate the association between phakic status and the risk of postoperative cystoid macular edema (CME) after implantation of Boston Keratoprosthesis Type I (Kpro). 2) To evaluate the association between iris-backplate touch (IBPT) on anterior segment optical coherence tomography (ASOCT) and the risk of postoperative CME after Kpro.

Methods: Retrospective non-interventional chart review. All patients who underwent Kpro type I implantation at the Illinois Eye and Ear Infirmary from 2007-2012 were reviewed. Patients were included in the study if they had at least one postoperative macular OCT and one postoperative ASOCT. Patients were excluded for poor quality images and aniridia. For all patients who met inclusion criteria, data were obtained including phakic status, pre-op and post-op visual acuity, time to final follow up, presence of CME on macular OCT and presence of IBPT on ASOCT. Two-tailed Fisher’s exact test was then performed to evaluate the statistical significance of phakic status and IBPT on postoperative CME.

Results: One hundred and three Kpro were implanted into 95 eyes of 94 patients over a 5 year period. Fifty-eight eyes met inclusion criteria. Seven eyes were excluded for poor image quality and aniridia. Of the remaining 51 eyes, 21 (41.1%) had CME on postoperative macular OCT and 9 (17.6%) were pseudophakic. On Fisher’s Exact Test there was a statistically significant positive correlation between implantation of pseudophakic-type keratoprosthesis and presence of postoperative CME (p = 0.023). On review of ASOCT, 23 (45.1%) had evidence of IBPT. There was no significant correlation found between IBPT and postoperative CME on Fisher’s exact test (p = 0.167).

Conclusions: CME is a frequent postoperative complication after Kpro implantation and can contribute to poor visual acuity outcomes. Patients with pseudophakic Kpros may be at higher risk for postoperative CME. Although IBPT may be a source of chronic inflammation in these patients, its presence on ASOCT is not a risk factor for postoperative CME.

Keywords: 575 keratoprostheses • 585 macula/fovea • 571 iris  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×